Deferred Tax Assets, Valuation Allowance of Adicet Bio, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Adicet Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Adicet Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $140,532,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $140,532,000 +$21,239,000 +18% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q4 2024 $119,293,000 +$20,224,000 +20% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q4 2023 $99,069,000 +$9,579,000 +11% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $89,490,000 +$16,327,000 +22% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q4 2021 $73,163,000 +$15,448,000 +27% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $57,715,000 +$37,900,000 +191% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $19,815,000 +$8,076,000 +69% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $11,739,000 +$6,429,000 +121% 31 Dec 2018 10-K 12 Mar 2021 2020 FY
Q4 2017 $5,310,000 31 Dec 2017 10-K 18 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.